These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27430638)

  • 1. Potential mechanisms of in-stent occlusion in the femoropopliteal artery: an angioscopic assessment.
    Ishihara T; Iida O; Okamoto S; Fujita M; Masuda M; Nanto K; Shiraki T; Kanda T; Tsujimura T; Okuno S; Yanaka K; Uematsu M
    Cardiovasc Interv Ther; 2017 Oct; 32(4):313-317. PubMed ID: 27430638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.
    Idemoto A; Okamoto N; Tanaka A; Mori N; Nakamura D; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Vasc Endovascular Surg; 2017 Jul; 51(5):335-337. PubMed ID: 28486842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioscopic Assessments at 3 Months After Fluoropolymer-Based Paclitaxel-Eluting Stent Implantation for Femoropopliteal Endovascular Intervention.
    Tsujimura T; Ishihara T; Iida O; Hata Y; Kurata N; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Matsuda Y; Mano T
    Circ J; 2020 Oct; 84(11):1999-2005. PubMed ID: 32981923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1105-1112. PubMed ID: 26117463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The First-in-Human High-Resolution Angioscopy of Superficial Femoral Arterial Rupture In-Stent Occlusion Due to Laser Photoablation.
    Haraguchi T; Kanno D; Fujita T; Hachinohe D; Kaneko U; Kashima Y; Sato K
    JACC Cardiovasc Interv; 2021 Dec; 14(23):e321-e322. PubMed ID: 34774472
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and clinical impact of restenosis after femoropopliteal stenting.
    Tosaka A; Soga Y; Iida O; Ishihara T; Hirano K; Suzuki K; Yokoi H; Nanto S; Nobuyoshi M
    J Am Coll Cardiol; 2012 Jan; 59(1):16-23. PubMed ID: 22192663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Endovascular Therapy, AGET, for In-Stent Occlusions in Iliac and Femoropopliteal Arteries.
    Nishino M; Egami Y; Nakamura H; Kawanami S; Sugae H; Ukita K; Kawamura A; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Yano M; Tanouchi J
    Int Heart J; 2022 Sep; 63(5):874-880. PubMed ID: 36104233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive arterial repair one year after paclitaxel-coated nitinol drug-eluting stent vs. bare-metal stent implantation in the superficial femoral artery.
    Ishihara T; Iida O; Awata M; Nanto K; Shiraki T; Okamoto S; Iida T; Fujita M; Watanabe T; Nanto S; Uematsu M
    Cardiovasc Interv Ther; 2015 Jan; 30(1):51-6. PubMed ID: 25085265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioscopic Findings of Stenosis Versus Occlusion in Femoropopliteal Artery Disease.
    Tashiro K; Mori H; Tezuka T; Omura A; Wada D; Sone H; Takei Y; Sasai M; Sato T; Suzuki H
    J Endovasc Ther; 2023 Apr; 30(2):223-231. PubMed ID: 35179063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2016 Apr; 9(8):828-834. PubMed ID: 27101908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-related long-term outcome of primary femoropopliteal stent placement for peripheral artery disease.
    Stavroulakis K; Donas KP; Torsello G; Osada N; Schönefeld E
    J Endovasc Ther; 2015 Feb; 22(1):31-7. PubMed ID: 25775677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Cauterized Tissue Using Laser Photoablation for In-Stent Occlusion of Superficial Femoral Artery.
    Sakio T; Egami Y; Nakamura H; Matsunaga-Lee Y; Yano M; Nishino M; Tanouchi J
    JACC Cardiovasc Interv; 2023 Feb; 16(3):347-348. PubMed ID: 36609042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.